FR 7111 2015 16112
User Manual: FR-7111
Open the PDF directly: View PDF 
.
Page Count: 8
37719
Federal Register / Vol. 80, No. 126 / Wednesday, July 1, 2015 / Notices
and may be renewed upon application
for additional two year periods. In
accordance with 49 U.S.C. 31136(e) and
31315, each of the 23 applicants has
satisfied the entry conditions for
obtaining an exemption from the vision
requirements (65 FR 66286; 66 FR
13825; 66 FR 30502; 66 FR 33990; 66 FR
41654; 67 FR 76439; 68 FR 10298; 68 FR
10300; 68 FR 19598; 68 FR 33570; 68 FR
44837; 70 FR 7545; 70 FR 7546; 70 FR
25878; 70 FR 41811; 71 FR 14566; 71 FR
30227; 72 FR 180; 72 FR 7111; 72 FR
7812; 72 FR 8417; 72 FR 9397; 72 FR
28093; 72 FR 36099; 72 FR 39879; 72 FR
40362; 72 FR 52419; 73 FR 27014; 73 FR
38497; 73 FR 48271; 73 FR 51689; 73 FR
63047; 74 FR 6212; 74 FR 19270; 74 FR
26466; 74 FR 34395; 75 FR 50799; 75 FR
66423; 75 FR 77590; 76 FR 9861; 76 FR
17481; 76 FR 18824; 76 FR 21796; 76 FR
25762; 76 FR 25766; 76 FR 28125; 76 FR
29024; 76 FR 37885; 76 FR 44652; 77 FR
70537; 78 FR 10250; 78 FR 14410; 78 FR
24300; 78 FR 24798; 78 FR 27281; 78 FR
37270; 78 FR 41188; 78 FR 46407; 78 FR
51268; 78 FR 56993; 79 FR 24298). Each
of these 23 applicants has requested
renewal of the exemption and has
submitted evidence showing that the
vision in the better eye continues to
meet the requirement specified at 49
CFR 391.41(b)(10) and that the vision
impairment is stable. In addition, a
review of each record of safety while
driving with the respective vision
deficiencies over the past two years
indicates each applicant continues to
meet the vision exemption
requirements.
These factors provide an adequate
basis for predicting each driver’s ability
to continue to drive safely in interstate
commerce. Therefore, FMCSA
concludes that extending the exemption
for each renewal applicant for a period
of two years is likely to achieve a level
of safety equal to that existing without
the exemption.
IV. Public Participation and Request for
Comments
FMCSA encourages you to participate
by submitting comments and related
materials.
Submitting Comments
If you submit a comment, please
include the docket number for this
notice (FMCSA–2000–7918; FMCSA–
2001–9561; FMCSA–2002–13411;
FMCSA–2003–14504; FMCSA–2006–
24015; FMCSA–2007–2663; FMCSA–
2007–25246; FMCSA–2007–27897;
FMCSA–2008–0174; FMCSA–2008–
0266; FMCSA–2011–0024; FMCSA–
2011–0057; FMCSA–2011–0092;
FMCSA–2013–0027; FMCSA–2013–
0028), indicate the specific section of
this document to which each comment
applies, and provide a reason for each
suggestion or recommendation. You
may submit your comments and
material online or by fax, mail, or hand
delivery, but please use only one of
these means. FMCSA recommends that
you include your name and a mailing
address, an email address, or a phone
number in the body of your document
so the Agency can contact you if it has
questions regarding your submission.
To submit your comment online, got
to http://www.regulations.gov and put
the docket number, ‘‘FMCSA–2000–
7918; FMCSA–2001–9561; FMCSA–
2002–13411; FMCSA–2003–14504;
FMCSA–2006–24015; FMCSA–2007–
2663; FMCSA–2007–25246; FMCSA–
2007–27897; FMCSA–2008–0174;
FMCSA–2008–0266; FMCSA–2011–
0024; FMCSA–2011–0057; FMCSA–
2011–0092; FMCSA–2013–0027;
FMCSA–2013–0028’’ in the ‘‘Keyword’’
box, and click ‘‘Search.’’ When the new
screen appears, click on ‘‘Comment
Now!’’ button and type your comment
into the text box in the following screen.
Choose whether you are submitting your
comment as an individual or on behalf
of a third party and then submit. If you
submit your comments by mail or hand
delivery, submit them in an unbound
format, no larger than 8
1
⁄
2
by 11 inches,
suitable for copying and electronic
filing. If you submit comments by mail
and would like to know that they
reached the facility, please enclose a
stamped, self-addressed postcard or
envelope. FMCSA will consider all
comments and material received during
the comment period and may change
this notice based on your comments.
Viewing Comments and Documents
To view comments, as well as any
documents mentioned in this preamble
as being available in the docket, go to
http://www.regulations.gov and in the
search box insert the docket number,
‘‘FMCSA–2000–7918; FMCSA–2001–
9561; FMCSA–2002–13411; FMCSA–
2003–14504; FMCSA–2006–24015;
FMCSA–2007–2663; FMCSA–2007–
25246; FMCSA–2007–27897; FMCSA–
2008–0174; FMCSA–2008–0266;
FMCSA–2011–0024; FMCSA–2011–
0057; FMCSA–2011–0092; FMCSA–
2013–0027; FMCSA–2013–0028’’ in the
‘‘Keyword’’ box and click ‘‘Search.’’
Next, click ‘‘Open Docket Folder’’
button choose the document listed to
review. If you do not have access to the
Internet, you may view the docket
online by visiting the Docket
Management Facility in Room W12–140
on the ground floor of the DOT West
Building, 1200 New Jersey Avenue SE.,
Washington, DC 20590, between 9 a.m.
and 5 p.m., e.t., Monday through Friday,
except Federal holidays.
Issued on: June 23, 2015.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2015–16138 Filed 6–30–15; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2015–0062]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
AGENCY
: Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION
: Notice of applications for
exemptions; request for comments.
SUMMARY
: FMCSA announces receipt of
applications from 49 individuals for
exemption from the prohibition against
persons with insulin-treated diabetes
mellitus (ITDM) operating commercial
motor vehicles (CMVs) in interstate
commerce. If granted, the exemptions
would enable these individuals with
ITDM to operate CMVs in interstate
commerce.
DATES
: Comments must be received on
or before July 31, 2015.
ADDRESSES
: You may submit comments
bearing the Federal Docket Management
System (FDMS) Docket No. FMCSA–
2015–0062 using any of the following
methods:
•Federal eRulemaking Portal: Go to
http://www.regulations.gov. Follow the
on-line instructions for submitting
comments.
•Mail: Docket Management Facility;
U.S. Department of Transportation, 1200
New Jersey Avenue SE., West Building
Ground Floor, Room W12–140,
Washington, DC 20590–0001.
•Hand Delivery: West Building
Ground Floor, Room W12–140, 1200
New Jersey Avenue SE., Washington,
DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal
Holidays.
•Fax: 1–202–493–2251.
Instructions: Each submission must
include the Agency name and the
docket numbers for this notice. Note
that all comments received will be
posted without change to http://
www.regulations.gov, including any
personal information provided. Please
see the Privacy Act heading below for
further information.
Docket: For access to the docket to
read background documents or
comments, go to http://
VerDate Sep<11>2014 18:30 Jun 30, 2015 Jkt 235001 PO 00000 Frm 00140 Fmt 4703 Sfmt 4703 E:\FR\FM\01JYN1.SGM 01JYN1
tkelley on DSK3SPTVN1PROD with NOTICES
37720
Federal Register / Vol. 80, No. 126 / Wednesday, July 1, 2015 / Notices
www.regulations.gov at any time or
Room W12–140 on the ground level of
the West Building, 1200 New Jersey
Avenue SE., Washington, DC, between 9
a.m. and 5 p.m., Monday through
Friday, except Federal holidays. The
Federal Docket Management System
(FDMS) is available 24 hours each day,
365 days each year. If you want
acknowledgment that we received your
comments, please include a self-
addressed, stamped envelope or
postcard or print the acknowledgement
page that appears after submitting
comments on-line.
Privacy Act: In accordance with 5
U.S.C. 553(c), DOT solicits comments
from the public to better inform its
rulemaking process. DOT posts these
comments, without edit, including any
personal information the commenter
provides, to www.regulations.gov, as
described in the system of records
notice (DOT/ALL–14 FDMS), which can
be reviewed at www.dot.gov/privacy.
FOR FURTHER INFORMATION CONTACT
:
Charles A. Horan, III, Director, Carrier,
Driver and Vehicle Safety Standards,
(202) 366–4001, fmcsamedical@dot.gov,
FMCSA, Department of Transportation,
1200 New Jersey Avenue SE., Room
W64–224, Washington, DC 20590–0001.
Office hours are from 8:30 a.m. to 5
p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION
:
I. Background
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the Federal Motor Carrier Safety
Regulations for a 2-year period if it finds
‘‘such exemption would likely achieve a
level of safety that is equivalent to or
greater than the level that would be
achieved absent such exemption.’’ The
statute also allows the Agency to renew
exemptions at the end of the 2-year
period. The 49 individuals listed in this
notice have recently requested such an
exemption from the diabetes prohibition
in 49 CFR 391.41(b) (3), which applies
to drivers of CMVs in interstate
commerce. Accordingly, the Agency
will evaluate the qualifications of each
applicant to determine whether granting
the exemption will achieve the required
level of safety mandated by statute.
II. Qualifications of Applicants
Adele M. Aasen
Ms. Aasen, 53, has had ITDM since
1971. Her endocrinologist examined her
in 2015 and certified that she has had
no severe hypoglycemic reactions
resulting in loss of consciousness,
requiring the assistance of another
person, or resulting in impaired
cognitive function that occurred without
warning in the past 12 months and no
recurrent (2 or more) severe
hypoglycemic episodes in the last 5
years. Her endocrinologist certifies that
Ms. Aasen understands diabetes
management and monitoring has stable
control of her diabetes using insulin,
and is able to drive a CMV safely. Ms.
Aasen meets the requirements of the
vision standard at 49 CFR 391.41(b)(10).
Her optometrist examined her in 2015
and certified that she does not have
diabetic retinopathy. She holds an
operator’s license from North Dakota.
Kyle E. Beine
Mr. Beine, 23, has had ITDM since
2004. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Beine understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Beine meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds an operator’s license from
Wisconsin.
Dean B. Bibens, Jr.
Mr. Bibens, 58, has had ITDM since
2002. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Bibens understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Bibens meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2014 and certified that
he does not have diabetic retinopathy.
He holds an operator’s license from
Connecticut.
Joseph M. Blackwell
Mr. Blackwell, 31, has had ITDM
since 2010. His endocrinologist
examined him in 2015 and certified that
he has had no severe hypoglycemic
reactions resulting in loss of
consciousness, requiring the assistance
of another person, or resulting in
impaired cognitive function that
occurred without warning in the past 12
months and no recurrent (2 or more)
severe hypoglycemic episodes in the
last 5 years. His endocrinologist certifies
that Mr. Blackwell understands diabetes
management and monitoring, has stable
control of his diabetes using insulin,
and is able to drive a CMV safely. Mr.
Blackwell meets the requirements of the
vision standard at 49 CFR 391.41(b)(10).
His optometrist examined him in 2015
and certified that he does not have
diabetic retinopathy. He holds an
operator’s license from Georgia.
Joseph G. Blastick
Mr. Blastick, 35, has had ITDM since
1987. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Blastick understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Blastick meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from South
Dakota.
Gary W. Boninsegna
Mr. Boninsegna, 58, has had ITDM
since 1991. His endocrinologist
examined him in 2015 and certified that
he has had no severe hypoglycemic
reactions resulting in loss of
consciousness, requiring the assistance
of another person, or resulting in
impaired cognitive function that
occurred without warning in the past 12
months and no recurrent (2 or more)
severe hypoglycemic episodes in the
last 5 years. His endocrinologist certifies
that Mr. Boninsegna understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Boninsegna meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he has stable
nonproliferative diabetic retinopathy.
He holds a Class B CDL from Ohio.
VerDate Sep<11>2014 18:30 Jun 30, 2015 Jkt 235001 PO 00000 Frm 00141 Fmt 4703 Sfmt 4703 E:\FR\FM\01JYN1.SGM 01JYN1
tkelley on DSK3SPTVN1PROD with NOTICES
37721
Federal Register / Vol. 80, No. 126 / Wednesday, July 1, 2015 / Notices
Brian K. Bouma
Mr. Bouma, 47, has had ITDM since
2015. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Bouma understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Bouma meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from Michigan.
Billy J. Bronson
Mr. Bronson, 60, has had ITDM since
2007. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Bronson understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Bronson meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he does not have
diabetic retinopathy. He holds a Class A
CDL from Oregon.
Michael L. Campbell
Mr. Campbell, 57, has had ITDM since
2011. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Campbell understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Campbell meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from North
Carolina.
Steven C. Cornell
Mr. Cornell, 45, has had ITDM since
2013. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Cornell understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Cornell meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from
Pennsylvania.
Josiah L. Crestik
Mr. Crestik, 24, has had ITDM since
1997. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Crestik understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Crestik meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds an operator’s license from
Minnesota.
Richard L. Cunningham
Mr. Cunningham, 66, has had ITDM
since 2010. His endocrinologist
examined him in 2015 and certified that
he has had no severe hypoglycemic
reactions resulting in loss of
consciousness, requiring the assistance
of another person, or resulting in
impaired cognitive function that
occurred without warning in the past 12
months and no recurrent (2 or more)
severe hypoglycemic episodes in the
last 5 years. His endocrinologist certifies
that Mr. Cunningham understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Cunningham meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds an operator’s license from
Nebraska.
Thomas M. Delasko
Mr. Delasko, 41, has had ITDM since
2005. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Delasko understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Delasko meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds an operator’s license from
Florida.
William T. Eason
Mr. Eason, 54, has had ITDM since
2011. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Eason understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Eason meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from North
Carolina.
Stefan D. Gall
Mr. Gall, 60, has had ITDM since
2008. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Gall understands
diabetes management and monitoring,
VerDate Sep<11>2014 18:30 Jun 30, 2015 Jkt 235001 PO 00000 Frm 00142 Fmt 4703 Sfmt 4703 E:\FR\FM\01JYN1.SGM 01JYN1
tkelley on DSK3SPTVN1PROD with NOTICES
37722
Federal Register / Vol. 80, No. 126 / Wednesday, July 1, 2015 / Notices
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Gall meets the requirements
of the vision standard at 49 CFR
391.41(b)(10). His optometrist examined
him in 2015 and certified that he does
not have diabetic retinopathy. He holds
a chauffeur’s license from Michigan.
Douglas J. Garrison
Mr. Garrison, 55, has had ITDM since
1990. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Garrison understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Garrison meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds an operator’s license from
Iowa.
Charles F. Gollahon
Mr. Gollahon, 81, has had ITDM since
2011. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Gollahon understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Gollahon meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2014 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from Ohio.
Donald E. Gray
Mr. Gray, 61, has had ITDM since
2014. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Gray understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Gray meets the requirements
of the vision standard at 49 CFR
391.41(b)(10). His ophthalmologist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from Florida.
Daniel W. Gregory
Mr. Gregory, 57, has had ITDM since
2014. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Gregory understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Gregory meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from North
Carolina.
Barry L. Grimes, Sr.
Mr. Grimes, 70, has had ITDM since
2013. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Grimes understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Grimes meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he does not have
diabetic retinopathy. He holds a Class A
CDL from Maryland.
Dennis J. Grimm
Mr. Grimm, 55, has had ITDM since
2014. His endocrinologist examined him
in 2014 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Grimm understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Grimm meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he does not have
diabetic retinopathy. He holds a Class A
CDL from Delaware.
Stephen G. Helmer
Mr. Helmer, 47, has had ITDM since
1996. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Helmer understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Helmer meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from Nebraska.
Kenneth P. Henry
Mr. Henry, 51, has had ITDM since
2008. His endocrinologist examined him
in 2014 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Henry understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Henry meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he has stable
nonproliferative diabetic retinopathy.
He holds a Class B CDL from
Washington.
Marco K. Higgs
Mr. Higgs, 41, has had ITDM since
1995. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
VerDate Sep<11>2014 18:30 Jun 30, 2015 Jkt 235001 PO 00000 Frm 00143 Fmt 4703 Sfmt 4703 E:\FR\FM\01JYN1.SGM 01JYN1
tkelley on DSK3SPTVN1PROD with NOTICES
37723
Federal Register / Vol. 80, No. 126 / Wednesday, July 1, 2015 / Notices
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Higgs understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Higgs meets the requirements
of the vision standard at 49 CFR
391.41(b)(10). His ophthalmologist
examined him in 2015 and certified that
he has stable nonproliferative diabetic
retinopathy. He holds an operator’s
license from Oregon.
Jeffrey T. Hunley
Mr. Hunley, 45, has had ITDM since
2010. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Hunley understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Hunley meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he has stable
nonproliferative diabetic retinopathy.
He holds a Class A CDL from North
Carolina.
Colin S. Jackson
Mr. Jackson, 32, has had ITDM since
1995. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Jackson understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Jackson meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds an operator’s license from
Washington.
Dennis J. Klawes
Mr. Klawes, 69, has had ITDM since
2013. His endocrinologist examined him
in 2014 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Klawes understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Klawes meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2014
and certified that he does not have
diabetic retinopathy. He holds a Class A
CDL from Wisconsin.
John E. Marshall
Mr. Marshall, 77, has had ITDM since
2006. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Marshall understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Marshall meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from
Pennsylvania.
Andrew Milite
Mr. Milite, 47, has had ITDM since
2011. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Milite understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Milite meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he does not have
diabetic retinopathy. He holds a Class B
CDL from New York.
Peter E. Mizialko
Mr. Mizialko, 53, has had ITDM since
2012. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Mizialko understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Mizialko meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from New
Jersey.
Matthew E. Modlin
Mr. Modlin, 25, has had ITDM since
2006. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Modlin understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Modlin meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he does not have
diabetic retinopathy. He holds an
operator’s license from North Carolina.
Michael I. Moore
Mr. Moore, 64, has had ITDM since
2003. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Moore understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Moore meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
VerDate Sep<11>2014 18:30 Jun 30, 2015 Jkt 235001 PO 00000 Frm 00144 Fmt 4703 Sfmt 4703 E:\FR\FM\01JYN1.SGM 01JYN1
tkelley on DSK3SPTVN1PROD with NOTICES
37724
Federal Register / Vol. 80, No. 126 / Wednesday, July 1, 2015 / Notices
he does not have diabetic retinopathy.
He holds a Class A CDL from Indiana.
Clyde S. Morgan
Mr. Morgan, 58, has had ITDM since
2015. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Morgan understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Morgan meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from
Minnesota.
Richard M. Ohland
Mr. Ohland, 55, has had ITDM since
2014. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Ohland understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Ohland meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from
Minnesota.
James D. Parrish
Mr. Parrish, 60, has had ITDM since
2014. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Parrish understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Parrish meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he does not have
diabetic retinopathy. He holds an
operator’s license from North Carolina.
Justin D. Redding
Mr. Redding, 42, has had ITDM since
2014. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Redding understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Redding meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he has stable
nonproliferative diabetic retinopathy.
He holds a Class A CDL from Montana.
Alex R. Rumph
Mr. Rumph, 30, has had ITDM since
1990. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Rumph understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Rumph meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he has stable
nonproliferative diabetic retinopathy.
He holds a Class A CDL from Montana.
Kenneth S. Schoenberger
Mr. Schoenberger, 57, has had ITDM
since 2012. His endocrinologist
examined him in 2015 and certified that
he has had no severe hypoglycemic
reactions resulting in loss of
consciousness, requiring the assistance
of another person, or resulting in
impaired cognitive function that
occurred without warning in the past 12
months and no recurrent (2 or more)
severe hypoglycemic episodes in the
last 5 years. His endocrinologist certifies
that Mr. Schoenberger understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Schoenberger meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from
Pennsylvania.
Jarred E. Shawles
Mr. Shawles, 29, has had ITDM since
1994. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Shawles understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Shawles meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from California.
Charles M. Smith
Mr. Smith, 42, has had ITDM since
2004. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Smith understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Smith meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from
Pennsylvania.
Howard L. Smith
Mr. Smith, 71, has had ITDM since
2014. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
VerDate Sep<11>2014 18:30 Jun 30, 2015 Jkt 235001 PO 00000 Frm 00145 Fmt 4703 Sfmt 4703 E:\FR\FM\01JYN1.SGM 01JYN1
tkelley on DSK3SPTVN1PROD with NOTICES
37725
Federal Register / Vol. 80, No. 126 / Wednesday, July 1, 2015 / Notices
certifies that Mr. Smith understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Smith meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he has stable
nonproliferative diabetic retinopathy.
He holds a Class A CDL from Illinois.
Jeffrey S. Snyder
Mr. Snyder, 51, has had ITDM since
2014. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Snyder understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Snyder meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he has stable
nonproliferative diabetic retinopathy.
He holds an operator’s license from
Pennsylvania.
Jerry L. Stevens
Mr. Stevens, 55, has had ITDM since
1975. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Stevens understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Stevens meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from Nebraska.
Todd A. Stover
Mr. Stover, 45, has had ITDM since
1990. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Stover understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Stover meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2014
and certified that he has stable
nonproliferative diabetic retinopathy.
He holds a Class A CDL from
Pennsylvania.
Kevin G. Sundquist
Mr. Sundquist, 32, has had ITDM
since 2009. His endocrinologist
examined him in 2015 and certified that
he has had no severe hypoglycemic
reactions resulting in loss of
consciousness, requiring the assistance
of another person, or resulting in
impaired cognitive function that
occurred without warning in the past 12
months and no recurrent (2 or more)
severe hypoglycemic episodes in the
last 5 years. His endocrinologist certifies
that Mr. Sundquist understands diabetes
management and monitoring, has stable
control of his diabetes using insulin,
and is able to drive a CMV safely. Mr.
Sundquist meets the requirements of the
vision standard at 49 CFR 391.41(b)(10).
His optometrist examined him in 2015
and certified that he does not have
diabetic retinopathy. He holds an
operator’s license from Minnesota.
David N. Tetlak
Mr. Tetlak, 36, has had ITDM since
1998. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Tetlak understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Tetlak meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds an operator’s license from
Pennsylvania.
Dennis P. Walker, Jr.
Mr. Walker, 40, has had ITDM since
2010. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Walker understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Walker meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds an operator’s license from
Ohio.
Horace V. Watson
Mr. Watson, 34, has had ITDM since
2009. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Watson understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Watson meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2015
and certified that he has stable
nonproliferative diabetic retinopathy.
He holds a Class B CDL from Georgia.
Jeremy W. Wolfe
Mr. Wolfe, 34, has had ITDM since
1982. His endocrinologist examined him
in 2015 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Wolfe understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Wolfe meets the
requirements of the vision standard at
49 CFR 391.41(b)(10). His optometrist
examined him in 2015 and certified that
he does not have diabetic retinopathy.
He holds an operator’s license from
Missouri.
VerDate Sep<11>2014 18:30 Jun 30, 2015 Jkt 235001 PO 00000 Frm 00146 Fmt 4703 Sfmt 4703 E:\FR\FM\01JYN1.SGM 01JYN1
tkelley on DSK3SPTVN1PROD with NOTICES
37726
Federal Register / Vol. 80, No. 126 / Wednesday, July 1, 2015 / Notices
1
Section 4129(a) refers to the 2003 notice as a
‘‘final rule.’’ However, the 2003 notice did not issue
a ‘‘final rule’’ but did establish the procedures and
standards for issuing exemptions for drivers with
ITDM.
III. Request for Comments
In accordance with 49 U.S.C. 31136(e)
and 31315, FMCSA requests public
comment from all interested persons on
the exemption petitions described in
this notice. We will consider all
comments received before the close of
business on the closing date indicated
in the date section of the notice.
FMCSA notes that section 4129 of the
Safe, Accountable, Flexible and
Efficient Transportation Equity Act: A
Legacy for Users requires the Secretary
to revise its diabetes exemption program
established on September 3, 2003 (68 FR
52441).
1
The revision must provide for
individual assessment of drivers with
diabetes mellitus, and be consistent
with the criteria described in section
4018 of the Transportation Equity Act
for the 21st Century (49 U.S.C. 31305).
Section 4129 requires: (1) Elimination
of the requirement for 3 years of
experience operating CMVs while being
treated with insulin; and (2)
establishment of a specified minimum
period of insulin use to demonstrate
stable control of diabetes before being
allowed to operate a CMV.
In response to section 4129, FMCSA
made immediate revisions to the
diabetes exemption program established
by the September 3, 2003 notice.
FMCSA discontinued use of the 3-year
driving experience and fulfilled the
requirements of section 4129 while
continuing to ensure that operation of
CMVs by drivers with ITDM will
achieve the requisite level of safety
required of all exemptions granted
under 49 U.S.C. 31136 (e).
Section 4129(d) also directed FMCSA
to ensure that drivers of CMVs with
ITDM are not held to a higher standard
than other drivers, with the exception of
limited operating, monitoring and
medical requirements that are deemed
medically necessary.
The FMCSA concluded that all of the
operating, monitoring and medical
requirements set out in the September 3,
2003 notice, except as modified, were in
compliance with section 4129(d).
Therefore, all of the requirements set
out in the September 3, 2003 notice,
except as modified by the notice in the
Federal Register on November 8, 2005
(70 FR 67777), remain in effect.
IV. Submitting Comments
You may submit your comments and
material online or by fax, mail, or hand
delivery, but please use only one of
these means. FMCSA recommends that
you include your name and a mailing
address, an email address, or a phone
number in the body of your document
so that FMCSA can contact you if there
are questions regarding your
submission.
To submit your comment online, go to
http://www.regulations.gov and in the
search box insert the docket number
FMCSA–2015–0062 and click the search
button. When the new screen appears,
click on the blue ‘‘Comment Now!’’
button on the right hand side of the
page. On the new page, enter
information required including the
specific section of this document to
which each comment applies, and
provide a reason for each suggestion or
recommendation. If you submit your
comments by mail or hand delivery,
submit them in an unbound format, no
larger than 8
1
⁄
2
by 11 inches, suitable for
copying and electronic filing. If you
submit comments by mail and would
like to know that they reached the
facility, please enclose a stamped, self-
addressed postcard or envelope.
We will consider all comments and
material received during the comment
period and may change this proposed
rule based on your comments. FMCSA
may issue a final rule at any time after
the close of the comment period.
V. Viewing Comments and Documents
To view comments, as well as any
documents mentioned in this preamble,
To submit your comment online, go to
http://www.regulations.gov and in the
search box insert the docket number
FMCSA–2015–0062 and click ‘‘Search.’’
Next, click ‘‘Open Docket Folder’’ and
you will find all documents and
comments related to the proposed
rulemaking.
Issued on June 23, 2015.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2015–16112 Filed 6–30–15; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2015–0057]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
AGENCY
: Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION
: Notice of final disposition.
SUMMARY
: FMCSA confirms its decision
to exempt 49 individuals from its rule
prohibiting persons with insulin-treated
diabetes mellitus (ITDM) from operating
commercial motor vehicles (CMVs) in
interstate commerce. The exemptions
enable these individuals to operate
CMVs in interstate commerce.
DATES
: The exemptions were effective
on May 9, 2015. The exemptions expire
on May 9, 2017.
FOR FURTHER INFORMATION CONTACT
:
Charles A. Horan, III, Director, Carrier,
Driver and Vehicle Safety Standards,
(202) 366–4001, fmcsamedical@dot.gov,
FMCSA, Room W64–224, Department of
Transportation, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION
:
I. Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: http://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to http://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey Avenue
SE., Washington, DC, between 9 a.m.
and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: In accordance with 5
U.S.C. 553(c), DOT solicits comments
from the public to better inform its
rulemaking process. DOT posts these
comments, without edit, including any
personal information the commenter
provides, to www.regulations.gov, as
described in the system of records
notice (DOT/ALL–14 FDMS), which can
be reviewed at www.dot.gov/privacy.
II. Background
On April 8, 2015, FMCSA published
a notice of receipt of Federal diabetes
exemption applications from 49
individuals and requested comments
from the public (80 FR 18928). The
public comment period closed on May
8, 2015, and one comment was received.
FMCSA has evaluated the eligibility
of the 49 applicants and determined that
granting the exemptions to these
individuals would achieve a level of
safety equivalent to or greater than the
level that would be achieved by
complying with the current regulation
49 CFR 391.41(b)(3).
II. Diabetes Mellitus and Driving
Experience of the Applicants
The Agency established the current
requirement for diabetes in 1970
because several risk studies indicated
that drivers with diabetes had a higher
VerDate Sep<11>2014 18:30 Jun 30, 2015 Jkt 235001 PO 00000 Frm 00147 Fmt 4703 Sfmt 4703 E:\FR\FM\01JYN1.SGM 01JYN1
tkelley on DSK3SPTVN1PROD with NOTICES
